Black Diamond Therapeutics Inc (BDTX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: BDTX Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-10-19 2023-10-17 B Purchase

BIOTECH GROWTH N V

Major owner
400,000 +4.9%
2.34
934,080 USD 		400,000 +4.9% 2.34 934,080 USD
2023-07-07 2023-07-05 B Purchase

RA CAPITAL MANAGEMENT, L.P.

Non-Executive Director
935,850 +41.1%
5.00
4,679,250 USD 		935,850 +41.1% 5.00 4,679,250 USD
2023-07-06 2023-07-05 B Purchase

Behbahani Ali

Non-Executive Director
1,000,000 +29.0%
5.00
5,000,000 USD 		1,000,000 +29.0% 5.00 5,000,000 USD
2023-07-03 2023-06-30 B Purchase

BIOTECH GROWTH N V

Major owner
1,000,000 +14.0%
5.00
5,000,000 USD 		1,000,000 +14.0% 5.00 5,000,000 USD
2023-06-29 2023-06-27 B Purchase

BIOTECH GROWTH N V

Major owner
1,740,000 +32.4%
5.49
9,555,036 USD 		1,740,000 +32.4% 5.49 9,555,036 USD
2023-06-28 2023-06-27 PS Planned sale

Epstein David M.

SEE REMARKS

Executive Director
25,000 -3.6%
6.70
167,500 USD 		25,000 -3.6% 6.70 167,500 USD
2022-12-23 2022-12-22 B Purchase

Ni Fang

SEE REMARKS

Officer
36,363 +40.8%
1.28
46,596 USD 		36,363 +40.8% 1.28 46,596 USD
2022-12-23 2022-12-21 B Purchase

Ni Fang

SEE REMARKS

Officer
20,000 +29.0%
1.29
25,770 USD 		20,000 +29.0% 1.29 25,770 USD
2022-11-02 2022-10-31 B Purchase

BIOTECH GROWTH N V

Major owner
99,801 +1.9%
2.25
224,912 USD 		99,801 +1.9% 2.25 224,912 USD
2022-10-31 2022-10-28 B Purchase

BIOTECH GROWTH N V

Major owner
172,974 +3.4%
2.18
376,962 USD 		172,974 +3.4% 2.18 376,962 USD
2022-10-31 2022-10-27 B Purchase

BIOTECH GROWTH N V

Major owner
191,678 +3.9%
1.87
359,224 USD 		191,678 +3.9% 1.87 359,224 USD
2022-10-25 2022-10-21 B Purchase

BIOTECH GROWTH N V

Major owner
87,850 +1.8%
1.51
132,750 USD 		87,850 +1.8% 1.51 132,750 USD
2022-10-21 2022-10-20 B Purchase

BIOTECH GROWTH N V

Major owner
53,734 +1.1%
1.42
76,345 USD 		53,734 +1.1% 1.42 76,345 USD
2022-10-21 2022-10-19 B Purchase

BIOTECH GROWTH N V

Major owner
77,689 +1.7%
1.32
102,775 USD 		77,689 +1.7% 1.32 102,775 USD
2022-04-29 2022-04-28 B Purchase

BIOTECH GROWTH N V

Major owner
255,711 +5.8%
2.57
657,868 USD 		255,711 +5.8% 2.57 657,868 USD
2022-04-29 2022-04-27 B Purchase

BIOTECH GROWTH N V

Major owner
150,000 +3.5%
2.66
399,480 USD 		150,000 +3.5% 2.66 399,480 USD
2022-04-20 2022-04-19 B Purchase

BIOTECH GROWTH N V

Major owner
150,000 +3.6%
3.24
486,645 USD 		150,000 +3.6% 3.24 486,645 USD
2022-04-20 2022-04-18 B Purchase

BIOTECH GROWTH N V

Major owner
150,000 +3.8%
3.29
493,935 USD 		150,000 +3.8% 3.29 493,935 USD
2022-04-14 2022-04-13 B Purchase

BIOTECH GROWTH N V

Major owner
102,556 +2.6%
3.57
366,217 USD 		102,556 +2.6% 3.57 366,217 USD
2022-04-14 2022-04-12 B Purchase

BIOTECH GROWTH N V

Major owner
150,000 +4.0%
3.42
513,600 USD 		150,000 +4.0% 3.42 513,600 USD
2021-05-05 2021-05-03 PS Planned sale

Roberts Christopher D.

Chief Scientific Officer

Officer
2,500 -43.9%
26.64
66,602 USD 		2,500 -43.9% 26.64 66,602 USD
2021-04-13 2021-04-12 PS Planned sale

Hatzis-Schoch Brent

See Remarks

Officer
4,078 -32.7%
25.00
101,950 USD 		4,078 -32.7% 25.00 101,950 USD
2021-04-07 2021-04-05 PS Planned sale

Roberts Christopher D.

Chief Scientific Officer

Officer
2,500 -43.9%
25.54
63,848 USD 		2,500 -43.9% 25.54 63,848 USD
2021-03-16 2021-03-12 PS Planned sale

Hatzis-Schoch Brent

See Remarks

Officer
4,078 -32.7%
26.36
107,493 USD 		4,078 -32.7% 26.36 107,493 USD
2021-03-04 2021-03-03 PS Planned sale

Roberts Christopher D.

Chief Scientific Officer

Officer
884 -21.6%
26.57
23,484 USD 		884 -21.6% 26.57 23,484 USD
2021-03-04 2021-03-03 PS Planned sale

Roberts Christopher D.

Chief Scientific Officer

Officer
1,616 -28.4%
25.85
41,778 USD 		1,616 -28.4% 25.85 41,778 USD
2021-02-12 2021-02-12 PS Planned sale

Hatzis-Schoch Brent

See Remarks

Officer
307 -3.5%
27.66
8,492 USD 		307 -3.5% 27.66 8,492 USD
2021-02-12 2021-02-12 PS Planned sale

Hatzis-Schoch Brent

See Remarks

Officer
3,771 -30.2%
27.19
102,533 USD 		3,771 -30.2% 27.19 102,533 USD
2021-02-04 2021-02-03 PS Planned sale

Roberts Christopher D.

Chief Scientific Officer

Officer
2,500 -43.9%
25.35
63,375 USD 		2,500 -43.9% 25.35 63,375 USD
2021-01-14 2021-01-12 PS Planned sale

Hatzis-Schoch Brent

See Remarks

Officer
7,511 -47.2%
36.00
270,395 USD 		7,511 -47.2% 36.00 270,395 USD
2021-01-14 2021-01-12 PS Planned sale

Hatzis-Schoch Brent

See Remarks

Officer
100 -0.6%
34.13
3,413 USD 		100 -0.6% 34.13 3,413 USD
2021-01-14 2021-01-12 PS Planned sale

Hatzis-Schoch Brent

See Remarks

Officer
103 -0.6%
32.50
3,347 USD 		103 -0.6% 32.50 3,347 USD
2021-01-14 2021-01-12 PS Planned sale

Hatzis-Schoch Brent

See Remarks

Officer
147 -0.9%
31.91
4,690 USD 		147 -0.9% 31.91 4,690 USD
2021-01-14 2021-01-12 PS Planned sale

Hatzis-Schoch Brent

See Remarks

Officer
1,669 -9.3%
30.50
50,912 USD 		1,669 -9.3% 30.50 50,912 USD
2021-01-14 2021-01-12 PS Planned sale

Hatzis-Schoch Brent

See Remarks

Officer
2,048 -10.3%
29.92
61,284 USD 		2,048 -10.3% 29.92 61,284 USD
2021-01-11 2021-01-08 PS Planned sale

Leggett Thomas

Chief Financial Officer

Officer
3,000 -100.0%
33.94
101,820 USD 		3,000 -100.0% 33.94 101,820 USD
2021-01-06 2021-01-04 PS Planned sale

Roberts Christopher D.

Chief Scientific Officer

Officer
537 -14.4%
31.78
17,065 USD 		537 -14.4% 31.78 17,065 USD
2021-01-06 2021-01-04 PS Planned sale

Roberts Christopher D.

Chief Scientific Officer

Officer
1,963 -34.4%
31.31
61,460 USD 		1,963 -34.4% 31.31 61,460 USD
2021-01-06 2021-01-04 PS Planned sale

Epstein David M.

See Remarks

Executive Director
2,015 -0.3%
31.80
64,075 USD 		2,015 -0.3% 31.80 64,075 USD
2021-01-06 2021-01-04 PS Planned sale

Epstein David M.

See Remarks

Executive Director
9,985 -1.4%
30.99
309,430 USD 		9,985 -1.4% 30.99 309,430 USD
2020-12-16 2020-12-14 PS Planned sale

Hatzis-Schoch Brent

See Remarks

Officer
4,078 -57.6%
34.95
142,522 USD 		4,078 -57.6% 34.95 142,522 USD
2020-12-10 2020-12-08 PS Planned sale

Leggett Thomas

Chief Financial Officer

Officer
1,941 -100.0%
34.05
66,094 USD 		1,941 -100.0% 34.05 66,094 USD
2020-12-10 2020-12-08 PS Planned sale

Leggett Thomas

Chief Financial Officer

Officer
1,059 -35.3%
33.27
35,233 USD 		1,059 -35.3% 33.27 35,233 USD
2020-12-04 2020-12-03 PS Planned sale

Roberts Christopher D.

Chief Scientific Officer

Officer
2,500 -100.0%
32.42
81,055 USD 		2,500 -100.0% 32.42 81,055 USD
2020-12-03 2020-12-01 PS Planned sale

Epstein David M.

See Remarks

Executive Director
1,077 -0.2%
33.45
36,021 USD 		1,077 -0.2% 33.45 36,021 USD
2020-12-03 2020-12-01 PS Planned sale

Epstein David M.

See Remarks

Executive Director
10,923 -1.5%
32.64
356,553 USD 		10,923 -1.5% 32.64 356,553 USD
2020-12-01 2020-11-30 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
200 -0.0%
34.16
6,833 USD 		200 -0.0% 34.16 6,833 USD
2020-12-01 2020-11-30 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
10,193 -1.2%
33.13
337,680 USD 		10,193 -1.2% 33.13 337,680 USD
2020-12-01 2020-11-30 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
200 -0.0%
34.16
6,833 USD 		200 -0.0% 34.16 6,833 USD
2020-12-01 2020-11-30 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
10,193 -1.2%
33.13
337,680 USD 		10,193 -1.2% 33.13 337,680 USD
2020-11-23 2020-11-19 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
114,854 -2.3%
33.01
3,791,331 USD 		114,854 -2.3% 33.01 3,791,331 USD
2020-11-23 2020-11-19 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
114,854 -2.3%
33.01
3,791,331 USD 		114,854 -2.3% 33.01 3,791,331 USD
2020-11-23 2020-11-19 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
15,163 -1.5%
33.01
500,531 USD 		15,163 -1.5% 33.01 500,531 USD
2020-11-23 2020-11-19 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
15,163 -1.5%
33.01
500,531 USD 		15,163 -1.5% 33.01 500,531 USD
2020-11-19 2020-11-18 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
473 -0.0%
33.09
15,653 USD 		473 -0.0% 33.09 15,653 USD
2020-11-19 2020-11-18 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
63 -0.0%
33.09
2,085 USD 		63 -0.0% 33.09 2,085 USD
2020-11-19 2020-11-18 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
473 -0.0%
33.09
15,653 USD 		473 -0.0% 33.09 15,653 USD
2020-11-19 2020-11-18 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
63 -0.0%
33.09
2,085 USD 		63 -0.0% 33.09 2,085 USD
2020-11-19 2020-11-17 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
3,705 -0.1%
33.05
122,450 USD 		3,705 -0.1% 33.05 122,450 USD
2020-11-19 2020-11-17 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
3,705 -0.1%
33.05
122,450 USD 		3,705 -0.1% 33.05 122,450 USD
2020-11-19 2020-11-17 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
489 -0.0%
33.05
16,161 USD 		489 -0.0% 33.05 16,161 USD
2020-11-19 2020-11-17 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
489 -0.0%
33.05
16,161 USD 		489 -0.0% 33.05 16,161 USD
2020-11-17 2020-11-16 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
177 -0.0%
33.01
5,843 USD 		177 -0.0% 33.01 5,843 USD
2020-11-17 2020-11-16 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
23 -0.0%
33.01
759 USD 		23 -0.0% 33.01 759 USD
2020-11-17 2020-11-16 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
177 -0.0%
33.01
5,843 USD 		177 -0.0% 33.01 5,843 USD
2020-11-17 2020-11-16 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
23 -0.0%
33.01
759 USD 		23 -0.0% 33.01 759 USD
2020-11-17 2020-11-13 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
1,502 -0.0%
34.53
51,865 USD 		1,502 -0.0% 34.53 51,865 USD
2020-11-17 2020-11-13 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
2,473 -0.1%
33.31
82,388 USD 		2,473 -0.1% 33.31 82,388 USD
2020-11-17 2020-11-13 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
198 -0.0%
34.53
6,837 USD 		198 -0.0% 34.53 6,837 USD
2020-11-17 2020-11-13 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
1,502 -0.0%
34.53
51,865 USD 		1,502 -0.0% 34.53 51,865 USD
2020-11-17 2020-11-13 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
2,473 -0.1%
33.31
82,388 USD 		2,473 -0.1% 33.31 82,388 USD
2020-11-17 2020-11-13 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
198 -0.0%
34.53
6,837 USD 		198 -0.0% 34.53 6,837 USD
2020-11-17 2020-11-13 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
327 -0.0%
33.31
10,894 USD 		327 -0.0% 33.31 10,894 USD
2020-11-17 2020-11-13 PS Planned sale

Bolzon Bradley J PhD

Non-Executive Director Major owner
327 -0.0%
33.31
10,894 USD 		327 -0.0% 33.31 10,894 USD
2020-11-13 2020-11-12 PS Planned sale

Versant Venture Capital VI, L.P.

Major owner
353 -0.0%
35.15
12,408 USD 		353 -0.0% 35.15 12,408 USD